Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Precision BioSciences to Present at Upcoming Virtual Investor Conferences in October
-
Precision BioSciences to Present at Upcoming Virtual Investor Conferences in October
-
5 Penny Stocks To Watch With Recent & Upcoming Biotech Events
-
LogicBio Therapeutics to Present at the 4th Annual Chardan Virtual Genetic Medicines Conference October 5, 2020
-
LogicBio Therapeutics to Present at the 4th Annual Chardan Virtual Genetic Medicines Conference October 5, 2020
-
Prevail Therapeutics to Present at Upcoming Investor Conferences
-
Prevail Therapeutics to Present at Upcoming Investor Conferences
-
Cabaletta Bio to Present at Upcoming Investor Conferences in October
-
Cabaletta Bio to Present at Upcoming Investor Conferences in October
-
Passage Bio to Participate in Upcoming October Investor Conferences
-
Freeline to participate in Chardan’s 4th Annual Genetic Medicines Conference
-
AVROBIO to Present at Two Upcoming Investor Conferences
-
Passage Bio to Participate in Upcoming October Investor Conferences
-
REGENXBIO to Participate in Upcoming Investor Conferences
-
Freeline to participate in Chardan’s 4th Annual Genetic Medicines Conference
-
Selecta Biosciences to Participate in Upcoming Investor Conferences
-
Taysha Gene Therapies (TSHA) IPO Opens 11% Higher
-
Krystal Biotech to Present at Upcoming Investor Conferences
-
Rocket Pharmaceuticals Announces Participation at Upcoming Conferences
-
Taysha Gene Therapies Announces Pricing of Initial Public Offering
-
Homology Medicines to Participate in Upcoming Conferences
-
UPDATE: Chardan Capital Markets Downgrades Seres Therapeutics (MCRB) to Neutral
-
Tottenham Acquisition I Limited Announces Filing of a Registration Statement on Form S-4 in Connection with its Proposed Business Combination with Clene Nanomedicine, Inc.
-
Immunovant Announces Closing of $200.0 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Kriya Therapeutics To Present At Upcoming Healthcare Conferences
-
Immatics Announces Second Quarter 2020 Financial Results and Business Update
-
Immatics Announces Second Quarter 2020 Financial Results and Business Update
-
Clene Nanomedicine, Inc. to go Public through Merger with Tottenham Acquisition I Limited
-
Immunovant (IMVT) Prices 5.27M Share Common Stock Offering at $33/Each
-
Immunovant Announces Pricing of Public Offering
-
Sensorion Announces Attendance and Presentations at Upcoming Conferences
-
Immunovant (IMVT) PT Raised to $45 at Chardan Capital Markets Following Data
-
Immunovant (IMVT) PT Raised to $35 at Chardan Capital Markets
-
Form 10-Q Chardan Healthcare Acqui For: Jun 30
-
Seres Therapeutics (MCRB) PT Raised to $32.50 at Chardan Capital Markets
-
Homology Medicines Reports Second Quarter 2020 Financial Results and Provides Business Update
-
Replimune Group (REPL) PT Raised to $30 at Chardan Capital Markets, Following Earnings
-
Health Sciences Acquisitions Corporation 2 Announces Closing of Upsized $160 Million Initial Public Offering, Including Full Exercise of the Underwriters' Over-Allotment Option
-
BankMobile Technologies and SPAC Megalith Financial Acquisition Corp. (MFAC) Agree to Combine
-
BankMobile Technologies, a Subsidiary of Customers Bank, and Megalith Financial Acquisition Corp. Agree to Combine to Bring a Digital Banking Platform to the Public Market under the New Name BM Techno
-
BankMobile Technologies, a Subsidiary of Customers Bank, and Megalith Financial Acquisition Corp. Agree to Combine to Bring a Digital Banking Platform to the Public Market under the New Name BM Techno
-
BankMobile Technologies, a Subsidiary of Customers Bank, and Megalith Financial Acquisition Corp. Agree to Combine to Bring a Digital Banking Platform to the Public Market under the New Name BM Techno
-
BankMobile Technologies, a Subsidiary of Customers Bank, and Megalith Financial Acquisition Corp. Agree to Combine to Bring a Digital Banking Platform to the Public Market under the New Name BM Techno
-
BankMobile Technologies, a Subsidiary of Customers Bank, and Megalith Financial Acquisition Corp. Agree to Combine to Bring a Digital Banking Platform to the Public Market under the New Name BM Techno
-
Regenxbio Inc. (RGNX) PT Lowered to $100 at Chardan Capital Markets, Following Drug Trial Update
-
Sonnet BioTherapeutics (SONN) Announces At-The-Market Warrant Repricing and Exchange Resulting in Expected Gross Proceeds to the Company of up to $10.5 Million
-
Sonnet BioTherapeutics Announces At-The-Market Warrant Repricing and Exchange Resulting in Expected Gross Proceeds to the Company of up to $10.5 Million
-
Health Sciences Acquisitions Corporation 2 Announces Pricing of Upsized $139.1 Million Initial Public Offering
-
uniQure Announces Second Quarter 2020 Financial Results and Highlights Recent Company Progress
-
Hudson Capital (HUSN) Announces $1.6M Registered Direct Offering of Ordinary Shares

